CITIUS ONCOLOGY, INC.
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 23, 2025 | Maxim Group | upgrade | Hold → Buy | $6 | 42% |
| May 23, 2025 | Maxim Group | downgrade | Buy → Hold | $0 | 42% |
| Nov 27, 2024 | Maxim Group | initiate | — → Buy | $3 | 42% |
| Aug 13, 2024 | EF Hutton | maintain | Buy → Buy | $6 | 30% |
No cross-platform signals in the last 90 days